California ephedrine
This article was originally published in The Tan Sheet
Executive Summary
Bill introduced by Assemblywoman Susan Davis (D) is now on state Senate calendar, scheduled for a June 26 hearing. HR 2294 would prohibit sale of supplements containing ephedrine unless labeling refers to potential adverse reactions and contraindications and provides warnings to those under 18 years of age (1"The Tan Sheet" March 6, In Brief). The bill was assigned to the Committee on Business & Profession June 8. California legislation passed earlier this year limits the amount of pseudoephedrine-containing OTCs that can be purchased at one time to curb illegal methamphetamine production. On Capitol Hill, S 486, which includes similar provisions, remains before the House Commerce/Health & Environment subcommittee (2"The Tan Sheet" June 5, p. 6)
You may also be interested in...
California Ephedrine Bill Slated For Senate Consideration Aug. 28
California legislation requiring warning labels on ephedra-containing dietary supplements passed out of the Senate Appropriations Committee Aug. 24 and is expected to go to the state Senate floor the week of Aug. 28. Assembly Bill 2294 was introduced by Assemblywoman Susan Davis (D) Feb. 24.
CHPA/Nevada AG Meth Retail Education Poster Campaign Under Way
Unusually large retail purchases of OTC cold, allergy, sinus and asthma medicines may signify the items are being used to produce methamphetamine in an illegal lab, recently distributed posters warn retail store clerks.
California ephedrine
Assembly bill No. 2294, introduced Feb. 24 by Susan Davis (D), would prohibit the sale or distribution of dietary supplements containing ephedrine unless labeling warns about potential adverse reactions and contraindications and states people under 18 should not take the product. The bill also would require labeling bear a toll-free number consumers could call to report adverse effects to the State Department of Health Services. The bill's introduction follows a February "informational" hearing chaired by Davis, whose district is in San Diego, where Metabolife International, manufacturer of the ephedra supplement Metabolife 356, is located. Similar measures are being considered by Texas and New York City; comments on the Texas proposed regs are due by April 4 (1"The Tan Sheet" Feb. 28, In Brief)